Reaction

Bone Debridement reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 482 reports · 8 co-occurring drugs

As of the last recalculation, Bone Debridement appears in 482 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is MELPHALAN (PRR 65.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Melphalan3265.065.1
Zoledronic Acid5363.964.0
Epoetin Alfa1660.360.4
Melphalan Hydrochloride3259.059.0
Thalidomide4152.652.7
Exemestane1735.535.5
Goserelin1032.832.8
Bicalutamide1131.931.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.